GENE ONLINE|News &
Opinion
Blog

2018-08-15| R&DTechnology

Transposon sheds light on genes associated with developmental brain diseases

by GeneOnline
Share To

The Laboratory of Neural Development and Stem Cell Research at the National Yang-Ming University identified 33 candidate genes associated with developmental brain diseases by screening transposon-mediated somatic mutagenesis. The study of this innovative genetic screening method and clinical discovery was published on Nature Communications.

By Joanne Shih

Many studies have proved that pediatric brain dysfunctions are associated with genetic mutations. Genetic mutations involved in the normal migration and function of cortical neurons often lead to developmental brain disorder, as known as malformations of cortical development (MCDs). MCDs can tremendously affect brain and neurological function, and often result in disorders such as autism, epilepsy, intellectual disability, developmental delay, microcephaly (small brain), and macrocephaly (large brain). However, many causal mutations involved in cortical development remain unknown.

Dr. Jin-Wu Tsai, principle investigator and associate professor at the Institute of Brain Science at National Yang-Ming University. Image source/National Yang-Ming University
Dr. Jin-Wu Tsai, principle investigator and associate professor at the Institute of Brain Science at National Yang-Ming University. Image source/National Yang-Ming University

“It is very difficult to identify genetic mutations causing developmental brain diseases, because most mutations happen in brain and it is hard to screen through every single gene” said Dr. Jin-Wu Tsai, the principle investigator and associate professor at the Institute of Brain Science at National Yang-Ming University. Inspired by Nobel laureate Dr. Barbara McClintock’s research in transposons, also known as “jumping genes”, Dr. Tsai and his team invented an in vivo genetic screening method based on transposon-mediated somatic mutagenesis.

In addition to developing the innovative screening method which can greatly shorten the time required for detecting mutant genes, Tsai’s team took a step forward to find out the clinical relevance of these 33 candidate genes associated with MCDs. They analyzed somatic mutations in brain tissue from patients with related disorders, and as a result they found that gene mutations are enriched in these identified candidate genes.

The research team has been collaborating with Taipei Veterans General Hospital, and helped pediatricians to screen and select treatment for patients with pediatric epilepsy. The new screening method and clinical finding are fundamental to developing potential indicators for early detection, diagnosis, and treatment for brain diseases.

Reference

  1. Lu IL, Chen C, Tung CY, et al. Identification of genes associated with cortical malformation using a transposon-mediated somatic mutagenesis screen in mice. Nat Commun. 2018 Jun 27;9(1):2498. doi: 10.1038/s41467-018-04880-8
  2. Institute of Brain Science, National Yang-Ming University
  3. The Laboratory of Neural Development and Stem Cell Research
  4. http://www.bcc.com.tw/newsView.3120953
  5. https://www.youtube.com/watch?v=fmPM2eIOPjg

 

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
A Look at the Billion Dollar Clinical Oncology NGS Market–Part I: Growth Driven by Regional Expansion & Targeted Technologies
2025-03-05
Anne Wojcicki’s Bold Move to Reclaim 23andMe Sparks Debate in Biotech Industry
2025-03-05
Cracking Cancer’s Code: How Genetic Testing Is Changing the Treatment Game
2025-02-20
LATEST
23andMe Files for Bankruptcy, DNA Data of 15 Million Users at Risk
2025-03-25
Psychedelics Inching Forward – Psilocybin Therapy Shows Sustained Benefits for Treatment-Resistant Depression
2025-03-24
Healthcare Through the Eyes of AI: Coding the Future of Medicine Through Digital Acceleration
2025-03-21
European Pharmaceutical Review Highlights RNA Therapeutics and Process Analytical Technology in 2025 Issue 1
2025-03-21
Study Examines Long-Term Effects of Anti-Amyloid Drug for Rare Alzheimer’s Variant
2025-03-21
Sanofi Acquires Bispecific Drug Candidate in $600 Million Deal Focused on Autoimmune Disorders
2025-03-21
Trump Administration Policies May Impact Health Care for Intersex Individuals
2025-03-21
EVENT
2025-04-21
World Vaccine Congress Washington 2025
Washington, U.S.A
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-04-26
SABPA OC/LA 17th Annual Biomedical Forum
Irvine, California, United States
2025-05-03
29th Taiwan Joint Cancer Conference 2025
Taipei, Taiwan
Scroll to Top